{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T22:25:01Z","timestamp":1783376701417,"version":"3.54.6"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s40264-023-01377-2","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T21:41:37Z","timestamp":1700170897000},"page":"195-204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The COVID-19 International Drug Pregnancy Registry (COVID-PR): Protocol Considerations"],"prefix":"10.1007","volume":"47","clinical-trial-number":[{"clinical-trial-number":"nct05013632","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6293-3429","authenticated-orcid":false,"given":"Diego F.","family":"Wyszynski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8143-2232","authenticated-orcid":false,"given":"Aris T.","family":"Papageorghiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7051-1653","authenticated-orcid":false,"given":"Cheryl","family":"Renz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8161-2353","authenticated-orcid":false,"given":"Torri D.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1458-7642","authenticated-orcid":false,"given":"Sonia","family":"Hern\u00e1ndez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"1377_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.923546","volume":"13","author":"S Adam","year":"2022","unstructured":"Adam S, Pheiffer C, Dias S, Hlongwane T, Vannevel V, Soma-Pillay P, et al. Coronavirus and pregnancy: the challenges of the 21(st) century: a review. Front Microbiol. 2022;13: 923546.","journal-title":"Front Microbiol"},{"issue":"2","key":"1377_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ajog.2021.08.054","volume":"226","author":"DJ Jamieson","year":"2022","unstructured":"Jamieson DJ, Rasmussen SA. An update on COVID-19 and pregnancy. Am J Obstet Gynecol. 2022;226(2):177\u201386.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"1377_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamapediatrics.2021.1050","volume":"175","author":"J Villar","year":"2021","unstructured":"Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort Study. JAMA Pediatr. 2021;175(8):817\u201326.","journal-title":"JAMA Pediatr"},{"issue":"10375","key":"1377_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0140-6736(22)02467-9","volume":"401","author":"J Villar","year":"2023","unstructured":"Villar J, Soto CCP, Gunier RB, Ariff S, Craik R, Cavoretto PI, et al. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study. Lancet. 2023;401(10375):447\u201357.","journal-title":"Lancet"},{"issue":"25","key":"1377_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.15585\/mmwr.mm6925a1","volume":"69","author":"S Ellington","year":"2020","unstructured":"Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status\u2014United States, January 22\u2013June 7, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(25):769\u201375.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"1377_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/aogs.13901","volume":"99","author":"J Collin","year":"2020","unstructured":"Collin J, Bystrom E, Carnahan A, Ahrne M. Public Health Agency of Sweden\u2019s brief report: pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden. Acta Obstet Gynecol Scand. 2020;99(7):819\u201322.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1377_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3320","volume":"370","author":"J Allotey","year":"2020","unstructured":"Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370: m3320.","journal-title":"BMJ"},{"issue":"5","key":"1377_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41577-022-00703-6","volume":"22","author":"V Male","year":"2022","unstructured":"Male V. SARS-CoV-2 infection and COVID-19 vaccination in pregnancy. Nat Rev Immunol. 2022;22(5):277\u201382.","journal-title":"Nat Rev Immunol"},{"key":"1377_CR9","unstructured":"Regulatory Affairs Professionals Society. COVID-19 therapeutics tracker 2022. Available from https:\/\/www.raps.org\/news-and-articles\/news-articles\/2020\/3\/covid-19-therapeutics-tracker. Accessed August 16, 2022."},{"key":"1377_CR10","doi-asserted-by":"publisher","first-page":"5302","DOI":"10.1016\/j.vaccine.2022.05.065","volume":"40","author":"V Pidiyar","year":"2022","unstructured":"Pidiyar V, Kumraj G, Ahmed K, Ahmed S, Shah S, Majumder P, et al. COVID-19 management landscape: a need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries. Vaccine. 2022;40:5302\u201312.","journal-title":"Vaccine"},{"key":"1377_CR11","unstructured":"World Health Organization (WHO). Therapeutics and COVID-19: living guideline 2023 [v13.1]. Available from: https:\/\/app.magicapp.org\/#\/guideline\/nBkO1E. Accessed April 5, 2023."},{"key":"1377_CR12","unstructured":"U.S. National Institutes of Health. Covid-19 treatment guidelines: clinical management of adults 2023. [updated May 2, 2023]. Available from https:\/\/www.covid19treatmentguidelines.nih.gov\/management\/clinical-management-of-adults\/clinical-management-of-adults-summary\/. Accessed June 19, 2023."},{"issue":"1","key":"1377_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12929-022-00852-9","volume":"29","author":"M Kumari","year":"2022","unstructured":"Kumari M, Lu RM, Li MC, Huang JL, Hsu FF, Ko SH, et al. A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies. J Biomed Sci. 2022;29(1):68.","journal-title":"J Biomed Sci"},{"key":"1377_CR14","unstructured":"U.S. Food and Drug Administration. Fact sheet for healthcare providers: Emergency use authorization for Lagevrio (molnupiravir) capsules 2022. Available from https:\/\/www.fda.gov\/media\/155054\/download. Accessed: August 17, 2022."},{"issue":"1","key":"1377_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jped.2018.07.008","volume":"96","author":"ERP Altafim","year":"2020","unstructured":"Altafim ERP, McCoy DC, Brentani A, Escobar AMU, Grisi S, Fink G. Measuring early childhood development in Brazil: validation of the caregiver reported early development instruments (CREDI). J Pediatr (Rio J). 2020;96(1):66\u201375.","journal-title":"J Pediatr (Rio J)"},{"issue":"1","key":"1377_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12887-020-02367-4","volume":"20","author":"Y Li","year":"2020","unstructured":"Li Y, Tang L, Bai Y, Zhao S, Shi Y. Reliability and validity of the caregiver reported early development instruments (CREDI) in impoverished regions of China. BMC Pediatr. 2020;20(1):475.","journal-title":"BMC Pediatr"},{"key":"1377_CR17","unstructured":"U.S. Centers for Disease Control and Prevention. Birth defects research and tracking 2021 [updated July 21, 2021]. Available from https:\/\/www.cdc.gov\/ncbddd\/birthdefects\/data.html. Accessed August 9, 2022."},{"key":"1377_CR18","unstructured":"U.S. Food and Drug Administration. 2023. Available from https:\/\/www.fda.gov. Accessed June 19, 2023."},{"key":"1377_CR19","unstructured":"European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). 2023. Available from: https:\/\/www.encepp.eu. Accessed June 19, 2023."},{"key":"1377_CR20","unstructured":"U.S. National Library of Medicine. ClinicalTrials.gov 2023. Available from: https:\/\/clinicaltrials.gov\/. Accessed June 19, 2023."},{"issue":"1","key":"1377_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2307\/2531248","volume":"42","author":"SL Zeger","year":"1986","unstructured":"Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121\u201330.","journal-title":"Biometrics"},{"key":"1377_CR22","unstructured":"European Commission. Regulation (EU) 2016\/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95\/46\/EC (General Data Protection Regulation). OJ2016. p. 1\u201388."},{"key":"1377_CR23","unstructured":"International Committee of Medical Journal Editors. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals 2019. Available from: http:\/\/www.icmje.org\/recommendations\/. Accessed July 27, 2022."},{"issue":"4","key":"1377_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/pds.3731","volume":"24","author":"AV Margulis","year":"2015","unstructured":"Margulis AV, Mittleman MA, Glynn RJ, Holmes LB, Hernandez-Diaz S. Effects of gestational age at enrollment in pregnancy exposure registries. Pharmacoepidemiol Drug Saf. 2015;24(4):343\u201352.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1377_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12963-017-0122-8","volume":"15","author":"DC McCoy","year":"2017","unstructured":"McCoy DC, Sudfeld CR, Bellinger DC, Muhihi A, Ashery G, Weary TE, et al. Development and validation of an early childhood development scale for use in low-resourced settings. Popul Health Metr. 2017;15(1):3.","journal-title":"Popul Health Metr"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-023-01377-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-023-01377-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-023-01377-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T17:07:36Z","timestamp":1708189656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-023-01377-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["1377"],"URL":"https:\/\/doi.org\/10.1007\/s40264-023-01377-2","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]},"assertion":[{"value":"26 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The COVID-PR receives funding from the following sources: GSK, Merck Sharp and Dohme, Roche-Regeneron, and Gilead.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study protocol has been approved in the USA by the WCG IRB (20214420), in Japan by Medical Corporation TOUKEIKAI Kitamachi Clinic ERB (RVG0947720230315), and in Australia by The Bellberry Human Research Ethics Committee (2022-04-403). Clearance that approval is not required to conduct the study has been given by Ethics Committees in the following countries: Bulgaria, Canada, Croatia, Czech Republic, Denmark, Germany, Greece, Hong Kong, Italy, Malaysia, New Zealand, Poland, Romania, Singapore, South Africa, South Korea, and the UK. The study will be performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Participants will provide informed written consent before taking part in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Participants will provide informed written consent before taking part in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The COVID-PR protocol may be made available by the corresponding author on reasonable request, following applicable regulations.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Materials"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"The original study protocol was designed by DFW and SH-D. DFW and CR supervised data collection and data verification. SH-D, CR, ATP, and TDM provided advice on the study methodology and edited the first and final versions of the article. All authors have read and approved the final version of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}